Daniel Griffin provides a clinical update on COVID-19, then we review an Ad5 vectored SARS-CoV-2 vaccine, reports on remdesivir and hydroxychloroquine, a drug repurposing study, why some patients infect many others, reducing viral transmission, and much more, including listener email.

Hosts: Vincent Racaniello,Dickson Despommier, Alan Dove, Rich Condit, Kathy Spindler and Brianne Barker

Guests: Daniel Griffin and Chuck Knirsch

Subscribe (free): iTunes, Google Podcasts, RSS, email

Become a patron of TWiV!

Links for this episode

Safety of Ad5 vectored COVID-19 vaccine (Lancet)
Analysis of hydroxychloroquine use (Lancet)
Remdesivir study (NEJM)
Ancient COVID-19 history (MMWR)
Drug repurposing for COVID-19 (bioRxiv)
Why do few COVID-19 patients infect others? (Science)
Overdispersion in COVID-19 transmission (Wellcome Open Res)
Reducing airborne transmission (Science)
Letters read on TWiV 621
Timestamps by Jolene. Thanks!

Intro music is by Ronald Jenkees.

Send your virology questions and comments to twiv@microbe.tv

TWiV 621: An era of COVID-19 poppycock